CNS Pharmaceuticals CNSP
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 5.25 | 5 | -82.53 | -6 | -58.13 | 9 |
| 2025Q3 | 9.00 | 10 | -27.94 | -3 | -24.40 | 12 |
| 2025Q2 | 9.90 | 13 | -19.71 | -2 | -16.81 | 15 |
| 2025Q1 | 16.32 | 11 | -50.17 | -4 | -38.32 | 14 |
| 2024Q4 | 72.24 | 6 | -66.66 | -3 | -39.43 | 9 |
| 2024Q3 | 78.30 | 3 | -6 | -113.50 | 7 | |
| 2024Q2 | 948.00 | -4 | -3 | -122.57 | 2 | |
| 2024Q1 | 10860.00 | -4 | -4 | -210.89 | 2 | |
| 2023Q4 | 38100.00 | -4 | -5 | -266.82 | 2 | |
| 2023Q3 | 34200.00 | -2 | -5 | -103.03 | 2 | |
| 2023Q2 | 66900.00 | 2 | -135.25 | -4 | -57.99 | 6 |
| 2023Q1 | 30000.00 | 3 | -84.85 | -5 | -48.19 | 7 |
| 2022Q4 | 72000.00 | 8 | -62.16 | -5 | -45.28 | 13 |
| 2022Q3 | 161100.00 | 8 | -30.65 | -3 | -27.64 | 10 |
| 2022Q2 | 252000.00 | 12 | -24.30 | -3 | -22.59 | 12 |
| 2022Q1 | 306900.00 | 15 | -25.99 | -3 | -22.61 | 16 |
| 2021Q4 | 632160.00 | 7 | -35.56 | -3 | -27.59 | 9 |
| 2021Q3 | 1341000.00 | 9 | -35.47 | -4 | -29.63 | 12 |
| 2021Q2 | 1764000.00 | 12 | -32.25 | -4 | -27.86 | 14 |
| 2021Q1 | 2151000.00 | 11 | -28.68 | -4 | -24.92 | 13 |